C07C59/10

Supported metal catalyst and use thereof for selective oxidation of glycerol

A method for oxidation of glycerol into glyceric acid is described, which includes a step of treating glycerol with a supported metal catalyst in the presence of oxygen, said catalyst including platinum and a metal element selected from the group comprising tin, molybdenum, bismuth and a mixture thereof.

Supported metal catalyst and use thereof for selective oxidation of glycerol

A method for oxidation of glycerol into glyceric acid is described, which includes a step of treating glycerol with a supported metal catalyst in the presence of oxygen, said catalyst including platinum and a metal element selected from the group comprising tin, molybdenum, bismuth and a mixture thereof.

Polymorphic compounds and uses thereof

The present invention provides freebase and salt forms, and compositions and methods thereof, useful for treating various conditions in which aldehyde toxicity is implicated in the pathogenesis by the administration of small molecule therapeutics acting as a scavenger for toxic aldehydes.

POLYMORPHIC COMPOUNDS AND USES THEREOF

The present invention provides freebase and salt forms, and compositions and methods thereof, useful for treating various conditions in which aldehyde toxicity is implicated in the pathogenesis by the administration of small molecule therapeutics acting as a scavenger for toxic aldehydes.

COMPOSITIONS AND METHODS FOR THE MODULATION OF CYTOKINES
20210163308 · 2021-06-03 ·

A method for modulating production of a cytokine, or molecule upregulated or down regulated by a cytokine, in a patient in need thereof, including administering to a patient a composition comprising at least one of a strontium-containing compound, a cysteine-based antioxidant, a polyhydroxyphenol and beta hydroxybutyric acid to the patient, whereby an amount of a cytokine in the patient is modulated.

COMPOSITIONS AND METHODS FOR THE MODULATION OF CYTOKINES
20210163308 · 2021-06-03 ·

A method for modulating production of a cytokine, or molecule upregulated or down regulated by a cytokine, in a patient in need thereof, including administering to a patient a composition comprising at least one of a strontium-containing compound, a cysteine-based antioxidant, a polyhydroxyphenol and beta hydroxybutyric acid to the patient, whereby an amount of a cytokine in the patient is modulated.

METHOD FOR THE PRODUCTION OF 2,4-DIHYDROXYBUTYRIC ACID
20210114964 · 2021-04-22 ·

Methods for the production of 2,4-dihydroxybutyrate (2,4-DHB) from erythrose and other four-carbon sugars are disclosed. The improved methods facilitate the production of 2,4-DHB that is a precursor for biorenewable and animal nutrition chemicals among others.

METHOD FOR THE PRODUCTION OF 2,4-DIHYDROXYBUTYRIC ACID
20210114964 · 2021-04-22 ·

Methods for the production of 2,4-dihydroxybutyrate (2,4-DHB) from erythrose and other four-carbon sugars are disclosed. The improved methods facilitate the production of 2,4-DHB that is a precursor for biorenewable and animal nutrition chemicals among others.

METHOD FOR THE PRODUCTION OF 2,4-DIHYDROXYBUTYRIC ACID
20210114964 · 2021-04-22 ·

Methods for the production of 2,4-dihydroxybutyrate (2,4-DHB) from erythrose and other four-carbon sugars are disclosed. The improved methods facilitate the production of 2,4-DHB that is a precursor for biorenewable and animal nutrition chemicals among others.

Method for the production of 2,4-dihydroxybutyric acid
10882812 · 2021-01-05 · ·

Methods for the production of 2,4-dihydroxybutyrate (2,4-DHB) from erythrulose and other four-carbon sugars are disclosed. The improved methods facilitate the production of 2,4-DHB that is a precursor for biorenewable and animal nutrition chemicals among others.